Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bangalore Genei is a pioneer in the Indian biotechnology industry, specializing in the development and manufacture of reagents, kits, and tools for life science research and education. Founded in 1989, the company was the first in India to produce restriction enzymes and other essential molecular biology reagents locally, significantly advancing the country's domestic research capabilities. Its product portfolio includes DNA polymerases, purification kits, protein markers, and specialized educational kits for academic laboratories. Following its acquisition by the Sanmar Group and later by Merck KGaA, the company's operations were integrated into Merck's global life science business. The "GeNei" brand remains a staple in Indian laboratories, known for its contribution to the indigenous development of biotech tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bangalore Genei.